Literature DB >> 23567540

Selecting significant genes by randomization test for cancer classification using gene expression data.

Zhiyi Mao1, Wensheng Cai, Xueguang Shao.   

Abstract

Gene selection is an important task in bioinformatics studies, because the accuracy of cancer classification generally depends upon the genes that have biological relevance to the classifying problems. In this work, randomization test (RT) is used as a gene selection method for dealing with gene expression data. In the method, a statistic derived from the statistics of the regression coefficients in a series of partial least squares discriminant analysis (PLSDA) models is used to evaluate the significance of the genes. Informative genes are selected for classifying the four gene expression datasets of prostate cancer, lung cancer, leukemia and non-small cell lung cancer (NSCLC) and the rationality of the results is validated by multiple linear regression (MLR) modeling and principal component analysis (PCA). With the selected genes, satisfactory results can be obtained.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cancer classification; Gene expression data; Gene selection; Partial least squares discriminant analysis; Randomization test

Mesh:

Year:  2013        PMID: 23567540     DOI: 10.1016/j.jbi.2013.03.009

Source DB:  PubMed          Journal:  J Biomed Inform        ISSN: 1532-0464            Impact factor:   6.317


  3 in total

1.  Feature Genes Selection Using Supervised Locally Linear Embedding and Correlation Coefficient for Microarray Classification.

Authors:  Jiucheng Xu; Huiyu Mu; Yun Wang; Fangzhou Huang
Journal:  Comput Math Methods Med       Date:  2018-01-31       Impact factor: 2.238

2.  Hybrid Method Based on Information Gain and Support Vector Machine for Gene Selection in Cancer Classification.

Authors:  Lingyun Gao; Mingquan Ye; Xiaojie Lu; Daobin Huang
Journal:  Genomics Proteomics Bioinformatics       Date:  2017-12-12       Impact factor: 7.691

3.  The Gasdermin E Gene Has Potential as a Pan-Cancer Biomarker, While Discriminating between Different Tumor Types.

Authors:  Joe Ibrahim; Ken Op de Beeck; Erik Fransen; Marc Peeters; Guy Van Camp
Journal:  Cancers (Basel)       Date:  2019-11-18       Impact factor: 6.639

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.